{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:14:03Z","timestamp":1783692843241,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,4,1]],"date-time":"1985-04-01T00:00:00Z","timestamp":481161600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"published-print":{"date-parts":[[1985,4]]},"DOI":"10.1007\/bf01059394","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T15:25:42Z","timestamp":1107012342000},"page":"121-142","source":"Crossref","is-referenced-by-count":27,"title":["The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination"],"prefix":"10.1007","volume":"13","author":[{"given":"R. M. J.","family":"Ings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. S.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. O.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.","family":"Bywater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. A.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1985,4,1]]},"reference":[{"key":"BF01059394_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/jac\/4.5.445","volume":"4","author":"F. A. Draser","year":"1978","unstructured":"F. A. Draser, W. Farrell, A. J. Howard, C. Hince, T. Leung, and J. D. Williams. Activity of HR 756 againstHaemophilus Influenzae, Bacteriodes fragilis, and gram-negative rods.J. Antimicrob. Chemother. 4:445\u2013450 (1978).","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01059394_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000237902","volume":"26","author":"G. Peters","year":"1980","unstructured":"G. Peters and G. Pulverer. Comparativein vitro activity of cefotaxime (HR756).Chemotherapy 26:177\u2013183 (1980).","journal-title":"Chemotherapy"},{"key":"BF01059394_CR3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.14.6.876","volume":"14","author":"J. B. Sosna","year":"1978","unstructured":"J. B. Sosna, P. R. Murray, G. Modoff. Comparison ofin vitro activities of HR756 with cephalothin, cefoxitin and cepharnandole.Antimicrob. Agents Chemother. 14:876\u2013879 (1978).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"suppl A","key":"BF01059394_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/6.suppl_A.13","volume":"6","author":"M. H. Richmond","year":"1980","unstructured":"M. H. Richmond.\u03b2-Lactamase stability of cefotaxime.J. Antimicrob. Chemother. 6(suppl A):13\u201317 (1980).","journal-title":"J. Antimicrob. Chemother."},{"issue":"suppl A","key":"BF01059394_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/6.suppl_A.93","volume":"6","author":"D. S. Reeves","year":"1980","unstructured":"D. S. Reeves, L. O. White, H. A. Holt, D. Bahari, M. J. Bywater, and R. P. Bax. Human metabolism of cefotaxime.J. Antimicrob. Chemotherapy 6(suppl A):93\u2013101 (1980).","journal-title":"J. Antimicrob. Chemotherapy"},{"issue":"suppl A","key":"BF01059394_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/6.suppl_A.69","volume":"6","author":"J. Chamberlain","year":"1980","unstructured":"J. Chamberlain, J. D. Coombes, D. Dell, J. M. Fromson, R. M. J. Ings, C. M. Macdonald, and J. McEwen. Metabolism of cefotaxime in animals and man.J. Antimicrob. Chemother. 6(suppl A):69\u201378 (1980).","journal-title":"J. Antimicrob. Chemother."},{"issue":"suppl A","key":"BF01059394_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/6.suppl_A.25","volume":"6","author":"E. Schrinner","year":"1980","unstructured":"E. Schrinner, M. Limbert, L. Penasse, and A. Lutz. Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro andin vivo).J. Antimicrob. Chemother. 6(suppl A):25\u201330 (1980).","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01059394_CR8","first-page":"153","volume-title":"Current Chemotherapy and Infectious Disease","author":"L. O. White","year":"1980","unstructured":"L. O. White, H. A. Holt, D. S. Reeves, M. J. Bywater, and R. P. Bax. Separation of assay of cefotaxime (HR756) and its metabolites in serum, urine, and bile. In J. D. Nelson, and C. Grassi (eds.),Current Chemotherapy and Infectious Disease. Proceedings of the 11th International Congress of Chemotherapy and the 19th Interscience Conference oq Antimicrobial Agents and Chemotherapy. The American Society for Microbiology, Washington D.C., 1980, pp. 153\u2013154."},{"key":"BF01059394_CR9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AEM.14.2.170-177.1966","volume":"14","author":"J. V. Bennett","year":"1966","unstructured":"J. V. Bennett, J. L. Brodie, E. J. Benner, and W. M. N. Kirby. Simplified, accurate method for antibiotic assay of clinical specimens.Appl. Microbiol. 14:170\u2013177 (1966).","journal-title":"Appl. Microbiol."},{"issue":"suppl A","key":"BF01059394_CR10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/6.suppl_A.83","volume":"6","author":"F. Esmieu","year":"1980","unstructured":"F. Esmieu, J. Guilbert, H. C. Rosenkilde, I. Ho, and A. Le Go. Pharmacokinetics of cefotaxime in normal human volunteers.J. Antimicrob. Chemother. 6(suppl A):83\u201392 (1980).","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01059394_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01066064","volume":"6","author":"K. C. Yeh","year":"1978","unstructured":"K. C. Yeh and K. C. Kwan. A comparison of numerical integrating algorithms by trapezoidal, lagrange, and spline approximation.J. Pharmacokin. Biopharm. 6:79\u201398 (1978).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059394_CR12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0163-7258(81)90056-5","volume":"15","author":"J. B. Houston","year":"1982","unstructured":"J. B. Houston. Drug metabolite kinetics.Pharmacol. Ther. 15:521\u2013552 (1982).","journal-title":"Pharmacol. Ther."},{"key":"BF01059394_CR13","first-page":"150","volume-title":"Introduction to Statistical Analysis","author":"W. J. Dixon","year":"1969","unstructured":"W. J. Dixon and F. J. Massey. Analysis of variance. InIntroduction to Statistical Analysis. McGraw-Hill Book Co. Inc., New York, 1969, pp. 150\u2013187."},{"key":"BF01059394_CR14","first-page":"236","volume-title":"Introduction to Statistics","author":"R. E. Walpole","year":"1972","unstructured":"R. E. Walpole. Tests for paired observation. InIntroduction to Statistics. Collier-Macmillan International, London, 1972, pp. 236\u2013241."},{"key":"BF01059394_CR15","first-page":"192","volume-title":"Principles and Perspectives in Drug Bioavailability","author":"W. J. Westlake","year":"1979","unstructured":"W. J. Westlake. Design and statistical evaluation of bioequivalence studies in man. In J. Blanchard, R. J. Sawchuk, and B. B. Brodie (eds.),Principles and Perspectives in Drug Bioavailability. S. Karger, Basel, 1979, pp. 192\u2013209."},{"key":"BF01059394_CR16","first-page":"149","volume-title":"Current Concepts in Pharmaceutical Sciences, Dosage Form Design and Bioavailability","author":"W. J. Westlake","year":"1973","unstructured":"W. J. Westlake. The design and analysis of comparative blood-level trials. In J. Swarbrick (ed.),Current Concepts in Pharmaceutical Sciences, Dosage Form Design and Bioavailability. Lea & Febiger, Philadelphia, 1973, pp. 149\u2013179."},{"key":"BF01059394_CR17","first-page":"7","volume-title":"Applied Regression Analysis","author":"N. R. Draper","year":"1966","unstructured":"N. R. Draper and H. Smith. Fitting a straight line by least squares. In N. R. Draper and H. Smith (ed.),Applied Regression Analysis. John Wiley & Sons Inc., New York, 1966, pp. 7\u201326."},{"key":"BF01059394_CR18","first-page":"334","volume-title":"Introduction to Statistical Analysis","author":"K. A. Browlee","year":"1969","unstructured":"K. A. Browlee. Simple linear regression. In W. J. Dixon and F. J. Massey, Jr. (eds.),Introduction to Statistical Analysis. McGraw-Hill, New York, 1969, pp. 334\u2013396."},{"key":"BF01059394_CR19","first-page":"592","volume":"16","author":"K. P. Fu","year":"1970","unstructured":"K. P. Fu, P. Aswapokee, I. Ho, C. Matthigssen, and H. C. Neu. Pharmacokinetics of cefotaxime.Antimicrob. Agents Chemother. 16:592\u2013597 (1970).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01059394_CR20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/AAC.16.2.127","volume":"16","author":"R. L\u00fcthy","year":"1979","unstructured":"R. L\u00fcthy, R. Munch, J. Blaser, H. Bhend, and W. Siegenthaler. Human pharmacology of cefotaxime (HR756), a new cephalosporin.Antimicrob. Agents Chemother. 16:127\u2013133 (1979).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01059394_CR21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1128\/AAC.20.5.567","volume":"20","author":"R. L\u00fcthy","year":"1981","unstructured":"R. L\u00fcthy, J. Blaser, A. Bonetti, H. Simson, R. Wise, and W. Siegenthaler. Comparative multiple dose pharmacokinetics of cefotaxime, moxalactam and ceftazidime.Antimicrob. Agents Chemother. 20:567\u2013575 (1981).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01059394_CR22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/clpt.1980.96","volume":"27","author":"H. C. Neu","year":"1980","unstructured":"H. C. Neu, P. Aswapokee, K. P. Fu, I. Ho, and C. Matthigssen. Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.Clin. Pharmacol. Ther. 27:677\u2013685 (1980).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059394_CR23","first-page":"873","volume-title":"The Pharmacological Basis of Therapeutics","author":"P. Brazeau","year":"1965","unstructured":"P. Brazeau. Inhibitors of tubular transport of organic compounds. In L. S. Goodman and A. Gilman (eds.),The Pharmacological Basis of Therapeutics. 3rd edition, The Macmillan Company, New York, 1965, pp. 873\u2013875.","edition":"3rd edition"},{"key":"BF01059394_CR24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/cpt196893345","volume":"9","author":"M. Gibaldi","year":"1968","unstructured":"M. Gibaldi and M. A. Schwartz. Apparent effect of probenecid on the distribution of penicillin in man.Clin. Pharmacol. Ther. 9:345\u2013349 (1968).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059394_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2125.1981.tb01132.x","volume":"11","author":"D. S. Reeves","year":"1981","unstructured":"D. S. Reeves, D. W. Bullock, M. J. Bywater, H. A. Holt, L. O. White, and D. P. Thornhill. The effect of probenecid on the pharmacokinetics and distribution of cefoxitin in healthy volunteers.Br. J. Clin. Pharmacol. 11:353\u2013359 (1981).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"suppl","key":"BF01059394_CR26","doi-asserted-by":"crossref","first-page":"S379","DOI":"10.1093\/clinids\/4.Supplement_2.S379","volume":"4","author":"R. M. J. Ings","year":"1982","unstructured":"R. M. J. Ings, J. P. Fillastre, M. Godin, A. Leroy, and G. Humbert. The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function.Rev. Infect. Dis. 4(suppl):S379\u2013S391 (1982).","journal-title":"Rev. Infect. Dis."},{"key":"BF01059394_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00609865","volume":"12","author":"P. E. Gower","year":"1977","unstructured":"P. E. Gower and C. H. Dash. The pharmacokinetics of cefuroxime after intravenous injection.Eur. J. Clin. Pharmacol. 12:221\u2013227 (1977).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BF01059394_CR28","first-page":"116","volume":"28","author":"M. Osmosu","year":"1980","unstructured":"M. Osmosu, O. Togashi, and K. Fugimoto. Pharmacokinetic study of cefotaxime in rabbits.Chemotherapy 28:116\u2013121 (1980).","journal-title":"Chemotherapy"}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01059394\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059394","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T13:43:52Z","timestamp":1586094232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01059394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,4]]}},"alternative-id":["BF01059394"],"URL":"https:\/\/doi.org\/10.1007\/bf01059394","relation":{},"ISSN":["0090-466X"],"issn-type":[{"value":"0090-466X","type":"print"}],"subject":[],"published":{"date-parts":[[1985,4]]}}}